← Back to results

FEBS J · 2016

Using CRISPR/Cas to study gene function and model disease in vivo.

The FEBS journal, 283(17): 3194-203 PMID 27149548 DOI 10.1111/febs.13750

Open in PubMed ↗ Open via DOI ↗

Abstract

The recent discovery of the CRISPR/Cas system and repurposing of this technology to edit a variety of different genomes have revolutionized an array of scientific fields, from genetics and translational research, to agriculture and bioproduction. In particular, the prospect of rapid and precise genome editing in laboratory animals by CRISPR/Cas has generated an immense interest in the scientific community. Here we review current in vivo applications of CRISPR/Cas and how this technology can improve our knowledge of gene function and our understanding of biological processes in animal models.

Cite